Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.
Çelen MK, Ertürk Şengel B, Kaya Ş, Demirtürk N, Azap A, Pullukçu H, Eroğlu E, Yıldırım F, Barut HŞ, Zerdali E, Sağmak Tartar A, Mete AÖ, Şahin AM, Mutay Suntur B, Sarı ND, Yılmaz E, Candevir A, Şimşek F, İnan D, Akhan S, Asan A, Günal Ö, Ural O, Parlak M, Çabalak M, Nazik S, Hızel K, Kınıklı S, Beştepe Dursun Z, Batırel A, Mermutluoğlu Ç. Çelen MK, et al. Among authors: pullukcu h. J Infect Dev Ctries. 2024 Mar 31;18(3):441-449. doi: 10.3855/jidc.17910. J Infect Dev Ctries. 2024. PMID: 38635621 Free article.
Rapid initiation of antiretroviral therapy in Turkey: a modeling study.
Yaylali E, Erdogan ZM, Calisir F, Pullukcu H, Yildirim F, Inan A, Aydin OA, Tekin S, Sonmezer MC, Sahin T, Ozcagli TG, Ozelgun B. Yaylali E, et al. Among authors: pullukcu h. Front Public Health. 2024 Jan 26;12:1224449. doi: 10.3389/fpubh.2024.1224449. eCollection 2024. Front Public Health. 2024. PMID: 38344235 Free PMC article.
The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study.
Başkol Elik D, Kaya Ş, Alkan S, Demirdal T, Sener A, Kaya S, Güzel Tunçcan Ö, Kayaaslan B, Güner R, Eser F, Kahraman H, Birengel S, Sarıcaoğlu EM, Eroğlu E, Çölkesen F, Öztürk E, Berk Cam H, Mermutluoğlu Ç, Özer Balin Ş, Sincan G, Altın N, Sili U, Suntur BM, Arslan Gülen T, Deveci B, Saba R, İncecik Ş, Eser Karlıdağ G, Hakko E, Akdağ D, Erdem HA, Sipahi H, Çicek C, Taşbakan MS, Taşbakan M, Pullukçu H, Yamazhan T, Arda B, Ulusoy S, Sipahi OR. Başkol Elik D, et al. Among authors: pullukcu h. Sci Rep. 2024 Mar 3;14(1):5218. doi: 10.1038/s41598-024-55886-w. Sci Rep. 2024. PMID: 38433274 Free PMC article.
COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey.
Soylu M, Sağıroğlu P, Özarslan MA, Acet O, Yüce ZT, İzci Çetinkaya F, Durmaz S, Parkan ÖM, Akyol D, Zeytinoğlu A, Kalın Ünüvar G, Taşbakan M, Gökahmetoğlu S, Atalay MA, Durusoy İR, Çiçek C, Pullukçu H, Yıldız O, Sertöz ŞR, Erensoy MS. Soylu M, et al. Among authors: pullukcu h. Vaccines (Basel). 2024 Jan 7;12(1):59. doi: 10.3390/vaccines12010059. Vaccines (Basel). 2024. PMID: 38250872 Free PMC article.
Impact of the empirical therapy timing on the clinical progress of septic shock patients.
Akyol D, Çankayalı İ, Ersel M, Demirağ K, Uyar M, Can Ö, Özçete E, Karbek-Akarca F, Yağdı T, Engin Ç, Özgiray E, Yurtseven T, Yağmur B, Nalbantgil S, Ekren P, Bozkurt D, Şirin H, Çilli F, Sezer ED, Taşbakan M, Yamazhan T, Pullukçu H, Sipahi H, Arda B, Ulusoy S, Sipahi OR. Akyol D, et al. Among authors: pullukcu h. Diagn Microbiol Infect Dis. 2024 Mar;108(3):116149. doi: 10.1016/j.diagmicrobio.2023.116149. Epub 2023 Nov 29. Diagn Microbiol Infect Dis. 2024. PMID: 38142580
The Impact of COVID-19 Infection on Macular Capillary Perfusion.
Baris ME, Degirmenci C, Yilmaz SG, Afrashi F, Pullukcu H, Tasbakan M. Baris ME, et al. Among authors: pullukcu h. Beyoglu Eye J. 2023 Dec 1;8(4):273-279. doi: 10.14744/bej.2023.13549. eCollection 2023. Beyoglu Eye J. 2023. PMID: 38089070 Free PMC article.
100 results